{"id":"W4232137107","doi":"10.3310/hta15suppl1-02","title":"Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years","year":2011,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Health Technology Assessment Programme; Hospital for Sick Children","keywords":"Omalizumab; Medicine; Nice; Asthma; Quality-adjusted life year; Cost effectiveness; Population; Quality of life (healthcare); Incremental cost-effectiveness ratio; Pediatrics; Economic evaluation; European union; Intensive care medicine; Internal medicine; Environmental health","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001547199,0.000150193,0.000386112,0.0002302656,0.0001003769,0.000002023362,0.0001270886,0.0001524345,0.00007961736],"category_scores_gemma":[0.00001029403,0.00009974327,0.0001779543,0.0002124722,0.0001641692,0.00001813508,0.00002607385,0.0001170327,0.00000345103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003204528,"about_ca_system_score_gemma":0.0004647939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001937589,"about_ca_topic_score_gemma":0.0001605093,"domain_scores_codex":[0.9988446,0.00004899577,0.0003620309,0.0002630611,0.0001415304,0.0003397836],"domain_scores_gemma":[0.9992335,0.00003699621,0.0001677127,0.0004345724,0.0000381339,0.00008905606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003138196,0.003053604,0.8556765,0.0001166661,0.0003106693,0.0000350325,0.0009014382,0.00001684678,0.00003066559,0.002006598,0.0006048069,0.1369333],"study_design_scores_gemma":[0.003712623,0.005097141,0.9807974,0.00006605063,0.00005842213,0.00007105266,0.002015716,0.00005232504,0.00008513901,0.00007453485,0.007880475,0.00008915925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905434,0.004209987,0.00009997605,0.002816582,0.00007588053,0.002041523,0.00002719888,0.00008053069,0.0001049781],"genre_scores_gemma":[0.9963044,0.0007206918,0.002026186,0.0003291394,0.00002687857,0.0004393549,0.00001963281,0.0000193114,0.0001143975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1368441,"threshold_uncertainty_score":0.4067412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0313187190121669,"score_gpt":0.3288826945952632,"score_spread":0.2975639755830963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}